US Corporate Board Director Changes SEC Filings — October 20, 2026

USA Board Room Changes

By Gunpowder Editorial ·

23 high priority 23 total filings analysed

Executive Summary

Across the 23 filings in the USA Board Room Changes stream, the dominant theme is leadership and board refresh rather than financial performance: roughly two-thirds are Officer Change, Director Change or Board Change events, with new independent directors added at Vertex, Insmed, Northern Trust, Whirlpool, Entravision, Suja Life, Apollo, StubHub, Huntington Ingalls and PDS Biotechnology, and senior executive transitions at Fox, Clearfield, TJX, Southwest Gas, Live Oak, Newell and Laser Photonics.

Most filings contain no quantitative results, so period-over-period comparisons are available for only one company in depth: Neptune Insurance Holdings reported record Q3 2026 revenue up 34.3% YoY to $59.6M and net income up 49.9%, but net income margin fell 7.6pp over twelve months to 22.7% and Adjusted EBITDA margin improved only 1.5pp, with share-based compensation jumping from $0.1M to $7.0M. The most decision-relevant governance signals are the Laser Photonics CFO appointment alongside outside securities counsel and reporting consultants (a remediation-style pattern), the PDS Biotechnology reconstitution in which four directors resigned, the Clearfield CEO retirement with a search underway and a November 10 earnings date, and the Trade Desk option repricing that drew 232 million votes against. Market implication: board and officer churn is elevated and concentrated in small caps and biotech, while large-cap changes are mostly orderly succession and independence-enhancing additions.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from October 19, 2026.

Investment Signals (12)

  • Clearfield, Inc. ↓ (NEUTRAL-BULLISH)
    ▲

    Fiscal 2026 Q4 and full-year results expected in line with prior guidance on preliminary unaudited data; CEO and co-founder Cheri Beranek retiring March 31, 2027, with results due November 10, 2026

  • Record Q3 2026 revenue of $59.6M (+34.3% YoY), net income +49.9% to $17.3M, written premium +31% to a record $132.7M, and Q3 net interest expense down 37.9% to $3.3M

  • Twelve-month net income flat at $44.7M while net income margin fell 7.6pp to 22.7%, indicating earnings growth is not keeping pace with the top line

  • ▲

    Adds former Sanofi CEO Paul Hudson and Verily CFO Utpal Koppikar as independent directors, strengthening commercial and capital-markets expertise ahead of its respiratory and immunology pipeline catalysts

  • ▲

    Adds Rima Qureshi (former Verizon chief strategy officer, 15 years on Mastercard board) as a director, reinforcing strategy and technology oversight at a major custody bank

  • ▲

    Appoints Karin Risi (28 years at Vanguard, led Personal Advisor build-out) to the Finance and HR committees, adding wealth-management and capital-allocation expertise

  • Appoints Tim Peterman as CFO alongside Sheppard Mullin securities counsel and CBIZ reporting consultants, with management framing it as building financial accountability

  • Four directors (Glover, Ali-Jackson, Freitag, Brawley) resigned and three new directors including John Dawson CBE were appointed, with new Audit and Compensation committees to support a Phase 3 PDS0301 trial

  • Trade Desk ↓ (NEUTRAL-BULLISH)
    ▲

    Option repricing to $12.26 approved by 441.1M for versus 232.5M against; repriced options revert if holders depart before April 19, 2027, limiting dilution and retention-cost risk

  • Silvia, Inc. (formerly ProCap Financial) (MIXED)
    ▲

    Announced more than $10M in annualized cost savings via compensation cuts, lower compute and personnel costs and renegotiated vendors, but impact is not quantified in detail

  • ▲

    Appoints Guillermo Beade (former SC Johnson CEO) as COO effective October 26, 2026, with enterprise authority over sales, marketing and supply chain following portfolio simplification

  • ▲

    Senior EVP Kenneth Canestrari steps down as executive officer January 31, 2027 with orderly retirement April 30, 2027 and removal from future LRPIP/SIP grants, a pre-planned transition with no financial disruption disclosed

Risk Flags (9)

  • New CFO plus outside securities counsel and external reporting consultants signal remediation of financial accountability and reporting processes; a material weakness or restatement risk is implied though not explicitly stated

  • Four of seven directors resigned concurrently with three appointments, a major governance reset that may reflect internal disagreement and raises execution risk on the Phase 3 timeline

  • Twelve-month net income margin fell 7.6pp to 22.7%, nine-month net margin fell 2.2pp, and share-based compensation rose from $0.1M to $7.0M, pressuring GAAP earnings quality

  • 232.5M votes against the option repricing (about 34% of votes cast), and Class B shares with 10 votes each give insiders outsized control over such proposals

  • CEO retirement effective March 31, 2027 with a search not yet begun; the company's growth record depends heavily on its co-founder, creating succession and strategy-continuity risk

  • Silvia, Inc./Cost-Cutting Signal [MEDIUM RISK]
    ▼

    Aggressive company-wide cuts and vendor renegotiations, with impact unquantified and deferred to the next update, may indicate prior cost discipline failures or near-term operating stress

  • Chief Legal and Policy Officer departs December 1, 2026 and government-relations reporting lines change at the same time, creating a double transition in legal and policy oversight

  • Senior Vice President and Chief Administrative Officer Randall Gabe retires by June 1, 2027, just ahead of the 2028 Great Basin Expansion project he is supporting, raising execution risk on that build-out

  • Chief Information and Digital Officer Renato Derraik departs November 6, 2026 with no successor named, leaving a gap in digital strategy at a bank in the middle of a technology push

Opportunities (8)

  • Record revenue, premium and Adjusted EBITDA growth (EBITDA +37.5% at a 61.7% margin) support a constructive view if net margin normalizes and share-based compensation stabilizes

  • Preliminary guidance confirmed as in line before the November 10 print, with a CEO search that may attract a higher-profile external leader and catalyze a re-rating

  • Board additions of a former Sanofi CEO and a Verily CFO bring big-pharma commercial and capital-markets experience into a company focused on respiratory and immunology launches

  • COO hire from SC Johnson, with a mandate to integrate sales, marketing and supply chain after portfolio simplification, is a structural lever for margin recovery in a consumer turnaround

  • A reconstituted board with new Audit and Compensation committees and the Wendel and Dawson appointments may accelerate PDS0101 partnering and the PDS0301 Phase 3 start

  • Silvia, Inc./Cost-Savings Leverage (OPPORTUNITY)
    ◆

    More than $10M in annualized savings on a small cost base could be meaningfully accretive if the figure is substantiated at the next financial update

  • Addition of a former Vanguard chief strategy officer to Finance and HR committees may sharpen capital-return and portfolio decisions at a cyclically exposed appliance maker

  • ◆

    Repricing to $12.26 restores incentive value for underwater employee options without new share authorization, which can reduce attrition risk and talent-retention costs

Sector Themes (6)

  • Biotech Board Refresh Wave
    ◆

    Insmed, PDS Biotechnology, Inhibikase and Vertex all added former big-pharma or biotech executives as directors (Hudson, Brawley-linked oncology expertise, Wasserman, Brennan), with 3 of 4 announced in the last week, signaling a push to add development and commercial credibility ahead of late-stage catalysts

  • CFO and Finance-Function Restructuring in Small Caps
    ◆

    Laser Photonics (new CFO plus external counsel and consultants) and Silvia (cost-cutting with new executives at a lower cost base) show that small caps with reporting or cost issues are responding with external advisers and leadership reshuffles, a pattern that merits extra scrutiny of controls

  • Succession Planning at Founder-Led and Long-Tenured Companies
    ◆

    Clearfield (co-founder CEO retiring), HII (former CEO returning to the board), Southwest Gas (30-year veteran retiring) and TJX (orderly retirement) show a steady flow of planned exits, with most companies giving 5 to 17 months' notice, which reduces the surprise risk of abrupt departures

  • Financial and Insurance Governance Gets Specialized Expertise
    ◆

    Northern Trust (Qureshi), Whirlpool (Risi), Vertex (Brennan) and Entravision (Ferrera on Audit) add audit, finance and strategy-focused directors, consistent with boards strengthening oversight of capital allocation and reporting

  • Compensation Mechanics Under Scrutiny
    ◆

    Trade Desk option repricing (232M against), Vertex's $400,000 RSU grant, Apollo's board expansion to 14 and Southwest Gas and TJX retirement benefit terms all reflect boards tying equity and retention design to shareholder expectations, with dissent concentrated where dilution or dual-class control is involved

  • Insurance and Fintech Growth Shows Margin Dilution
    ◆

    Neptune's strong top-line growth (+34%) alongside a 7.6pp decline in net margin and a $7M jump in share-based compensation suggests high-growth specialty finance is absorbing equity-compensation costs that compress GAAP returns

Watch List (8)

  • Q4 and full-year fiscal 2026 results and CEO succession update on November 10, 2026; watch for confirmation of guidance and any named CEO search firm or interim arrangements

  • New CFO Tim Peterman's first filings and any restatement, material-weakness or auditor-change disclosure following the CBIZ and Sheppard Mullin engagements; no date disclosed

  • Post-reconstitution progress on the PDS0301 Phase 3 trial start and PDS0101 partnership, plus any further director or committee changes; watch the next financial update

  • Subsequent insider option exercises and departures before the April 19, 2027 reversion date, and whether the 232M against vote drives further governance pressure from holders

  • Silvia, Inc. (formerly ProCap Financial)
    👁

    Quantification of the $10M-plus savings target at the next regularly scheduled financial update, with a check on whether cost cuts coincide with revenue weakness

  • Q4 2026 reporting on whether net margin stabilizes after the 7.6pp twelve-month decline and whether share-based compensation normalizes from the $7.0M quarterly run rate

  • Identification of a successor for Chief Information and Digital Officer Renato Derraik before his November 6, 2026 last day, and any digital-strategy disclosure

  • Progress on the 2028 Great Basin Expansion project and naming of a successor for Randall Gabe's Chief Administrative Officer role before the June 1, 2027 retirement

Filing Analyses (23)
Federal Home Loan Bank of Des Moines 8-K neutral materiality 3/10

20-10-2026

The Federal Home Loan Bank of Des Moines announced that Brett Manning has been appointed chief business officer, effective October 16, 2026, succeeding Wil W. Osborn, who became president and chief executive officer on October 1, 2026. Manning, who has been with the Bank since 1998 and most recently served as director of Member Strategies & Solutions, brings nearly 30 years of experience to the role. The filing reports a leadership transition only and contains no quantitative financial results.

  • · Manning joined the Bank in Seattle in 1998 and has held several business development and front-line risk management roles.
  • · Osborn previously served as chief business officer before becoming president and CEO on October 1, 2026.
  • · Manning holds a bachelor's degree in finance (minor in economics) from Western Washington University and is a Chartered Financial Analyst charterholder.
VERTEX PHARMACEUTICALS INC / MA 8-K neutral materiality 4/10

20-10-2026

Vertex Pharmaceuticals appointed Daniel Brennan, former EVP and Chief Financial Officer of Boston Scientific (retired June 2025), as a new independent board member on October 20, 2026, expanding the Board from ten to eleven members. Mr. Brennan also joined the Audit and Finance Committee and received a $400,000 restricted stock unit award vesting in October 2027. The filing discloses no related-party transactions or undisclosed arrangements tied to the appointment.

  • · Mr. Brennan was appointed to the Audit and Finance Committee at the time of joining the Board
  • · Prior roles: EVP and CFO of Boston Scientific (Jan 2014 to Jun 2025); SVP and Corporate Controller (2010 to 2013); various finance roles (1996 to 2009)
  • · Current outside board seats: Waters Corporation (since Nov 2022) and Madrigal Pharmaceuticals (since Aug 2025); former director of Nuance Corporation until its acquisition by Microsoft in March 2022
  • · Education: B.S. in Finance and Investments and M.B.A. from Babson College; certified public accountant
  • · Non-employee director compensation policy is detailed in Exhibit 10.45 to the FY2025 Form 10-K
  • · No Item 404(a) related-person transactions and no arrangement or understanding with other persons regarding the appointment
Fox Corp 8-K neutral materiality 3/10

20-10-2026

Fox Corporation announced that Adam Ciongoli, Chief Legal and Policy Officer, will not renew his contract and will step down effective December 1, 2026, transitioning to a special advisor role through June 2028. Nicholas Trutanich, currently Executive Vice President and Principal Deputy General Counsel, will become General Counsel effective the same date, reporting to Executive Chair and CEO Lachlan Murdoch. The change is a leadership succession within the legal function rather than a financial or operational event, with no financial metrics disclosed.

  • · Kristopher Jones, EVP and Head of Government Relations, will report directly to John Nallen, President and COO, effective December 1, 2026
  • · Trutanich previously served as U.S. Attorney for the District of Nevada (2019 to 2021) and joined Fox in 2021 as Chief Ethics & Compliance Officer
  • · Ciongoli's advisory role runs through June 2028, providing continuity of institutional knowledge
INSMED Inc 8-K positive materiality 4/10

20-10-2026

Insmed Incorporated (Nasdaq: INSM) appointed two new independent directors to its Board effective October 20, 2026: Paul Hudson, former CEO of Sanofi S.A. (September 2019 through February 2026) and former CEO of Novartis Pharmaceuticals, and Utpal Koppikar, CFO of Verily Health Inc. since April 2023 and former EVP and CFO of Atara Biotherapeutics. The filing is a board appointment announcement with no financial results, deal terms, or quantitative performance data disclosed.

  • · Koppikar currently serves on the Board of Directors of C4 Therapeutics, Inc. (Nasdaq: CCCC), a potential interlocking-directorship consideration
  • · Insmed's therapeutic focus areas are Respiratory, Immunology & Inflammation, and Neuro & Other Rare
  • · Insmed's research engine spans gene therapy, AI-driven protein engineering, RNA end-joining, and synthetic rescue
Laser Photonics Corp 8-K neutral materiality 5/10

20-10-2026

Laser Photonics Corp (NASDAQ: LASE) announced the appointment of Tim Peterman as Chief Financial Officer on October 20, 2026. The appointment, alongside the engagement of Sheppard, Mullin, Richter & Hampton LLP as outside securities counsel and CBIZ, Inc. for external financial reporting consulting, is framed by management as part of efforts to establish financial accountability, strengthen reporting processes and build governance. Mr. Peterman previously served as CEO of iMedia Brands (May 2019 to August 2023) and as its CFO (March 2015 to April 2018).

  • · Mr. Peterman holds a Bachelor of Science in accounting from the University of Kentucky and is a CPA with an inactive license
  • · Mr. Peterman began his career at KPMG in Chicago in 1989
  • · Sheppard will advise on securities law, SEC reporting obligations, corporate governance and capital markets matters
  • · CBIZ will help adopt best practices in external financial reporting and strengthen internal financial reporting controls and documentation
TJX COMPANIES INC /DE/ 8-K neutral materiality 3/10

20-10-2026

TJX Companies disclosed on October 15, 2026 that Senior Executive Vice President and Group President Kenneth Canestrari will step down as an executive officer effective January 31, 2027, while remaining employed until his scheduled retirement on April 30, 2027. The letter agreement extends his employment agreement to April 30, 2027, and removes him from the Management Incentive Plan, LRPIP (for performance periods beginning fiscal 2028 or later) and new SIP equity grants. The change is an orderly, pre-planned transition, with continuing non-compete and confidentiality obligations.

  • · Canestrari's employment agreement, dated February 2, 2018 and last amended February 2, 2024, is extended to April 30, 2027
  • · He ceases to be an executive officer effective January 31, 2027, but remains a Senior Executive Vice President until April 30, 2027
  • · He will receive special service recognition benefits on existing LRPIP and SIP awards after retirement, subject to plan terms
Clearfield, Inc. 8-K neutral materiality 6/10

20-10-2026

Clearfield, Inc. (NASDAQ: CLFD) announced that CEO and co-founder Cheri Beranek will retire as President and Chief Executive Officer effective March 31, 2027, and will remain at the company as President and CEO Emeritus in a non-director role after her successor is appointed. The Board, chaired by Catherine T. Kelly, will launch a search with a nationally recognized firm considering internal and external candidates. The company also expects fiscal 2026 fourth-quarter and full-year results to be in line with prior guidance, based on preliminary unaudited information, with results to be reported November 10, 2026.

  • · Beranek co-founded Clearfield in 2008 and is credited as key architect of product and market expansion
  • · Beranek remains in her role until the earlier of successor appointment or March 31, 2027
  • · Fiscal 2026 Q3 earnings call was held August 5, 2026, the reference point for Q4/full-year guidance
  • · Clearfield deploys more than a million fiber ports each year
WHIRLPOOL CORP /DE/ 8-K neutral materiality 3/10

20-10-2026

Whirlpool Corp. appointed Karin Risi to its board of directors effective immediately (announced October 19, 2026), with a seat on the Finance and Human Resources committees. Risi is a former Vanguard managing director and chief strategy and product officer with 28 years at Vanguard and more than 30 years of asset and wealth management experience. The filing is a board appointment rather than an executive departure, and it contains no financial results or guidance.

  • · Risi holds a bachelor's degree in finance and an MBA from Villanova University
  • · Risi currently serves as an independent director of SEI Investments Company and HarbourVest Partners
  • · Risi previously led the build and launch of Vanguard's Personal Advisor wealth management business
  • · Whirlpool describes itself as the only major U.S.-based manufacturer of kitchen and laundry appliances
NORTHERN TRUST CORP 8-K positive materiality 4/10

20-10-2026

Northern Trust (NTRS) announced the appointment of Rima Qureshi, former executive vice president and chief strategy officer of Verizon Communications, to its board of directors, effective immediately. Qureshi brings nearly four decades of strategy and transformation experience, including 23 years at Ericsson and more than 15 years on public company boards, including 15 years on the Mastercard board. The filing contains no financial results, so no period-over-period performance metrics are reported.

  • · Qureshi currently serves on the boards of BT Group plc, Loblaw Companies Limited and Swift
  • · Qureshi previously served as chief executive officer of Ericsson North America
  • · Qureshi joined Verizon in 2017
Neptune Insurance Holdings Inc. 8-K mixed materiality 7/10

20-10-2026

Neptune Insurance Holdings (NYSE: NP) reported record third quarter 2026 results, with revenue up 34.3% YoY to $59.6M, net income up 49.9% to $17.3M (29.0% margin), and Adjusted EBITDA up 37.5% to $36.8M (61.7% margin). Written premium grew 31% to a record $132.7M. However, Adjusted EBITDA margin (61.7%) is only modestly higher than the prior year (+1.5pp), nine-month net income margin contracted 2.2pp YoY, and twelve-month net income was essentially flat (+0.1%) as net income margin fell 7.6pp to 22.7%. Share-based compensation rose sharply to $7.0M from $0.1M, a major driver of the gap between Adjusted and GAAP earnings. The filing also references an officer change under Item 5.02.

  • · Nine-month revenue rose 32.3% to $153.2M; nine-month net income grew 22.2% to $40.4M, but net income margin fell 2.2pp to 26.4%
  • · Twelve-month net income margin fell 7.6pp to 22.7% while twelve-month net income was flat at $44.7M
  • · Q3 interest expense (net of interest income) fell 37.9% to $3.3M, supporting earnings
  • · Q3 income tax expense rose 88.7% to $7.5M, a meaningful drag on net income growth
  • · Share-based compensation rose to $7.0M in Q3 from $0.1M, widening the gap between GAAP and adjusted earnings
  • · Item 5.02 (officer change) is disclosed in this 8-K but its details are not included in the provided exhibit text
Southwest Gas Holdings, Inc. 8-K neutral materiality 3/10

20-10-2026

Randall P. Gabe, Senior Vice President and Chief Administrative Officer of Southwest Gas Corporation, notified the company on October 20, 2026 of his intention to retire on or before June 1, 2027, after 30 years of service. Until then he will serve as Senior Vice President/Business Development, supporting the 2028 Great Basin Expansion project and overseeing the Emerging Technology and Innovation team. The filing states the retirement was not the result of any disagreement with the company or Southwest Gas Holdings on operations, policies, or practices.

  • · Retirement is effective on or before June 1, 2027
  • · Gabe's new role is Senior Vice President/Business Development, with responsibility for the Emerging Technology and Innovation team through the effective date
  • · The filing explicitly states no disagreement with the company on operations, policies, or practices
Live Oak Bancshares, Inc. 8-K neutral materiality 3/10

20-10-2026

Live Oak Bancshares, Inc. disclosed that Renato Derraik, Chief Information & Digital Officer of Live Oak Banking Company, notified the company on October 14, 2026 of his resignation to pursue other endeavors. His last day of employment with the Bank will be November 6, 2026. The filing contains no financial results, guidance, or quantitative performance data, and no successor has been named in this disclosure.

  • · Resignation notice given October 14, 2026; effective last day of employment November 6, 2026
  • · Filing covers Item 5.02(b) departure of a certain officer; no successor or compensatory arrangements disclosed
AST SpaceMobile, Inc. 8-K neutral materiality 4/10

20-10-2026

AST SpaceMobile entered into a new three-year executive employment agreement with Andrew M. Johnson, its EVP, CFO and Chief Legal Officer, effective October 14, 2026, superseding his prior agreement. The agreement sets a base salary of not less than $250,000, bonus eligibility, RSU eligibility under the 2024 Incentive Award Plan, and severance of 12 months' base salary plus up to 12 months of COBRA subsidy and accelerated vesting on termination without Cause, for Good Reason, or on non-renewal.

  • · Johnson's agreement carries a non-compete and confidentiality/invention assignment covenants under a previously executed agreement, with severance conditioned on a release of claims and continued compliance
  • · Johnson holds the combined CFO and Chief Legal Officer roles, and is also an Eligible Employee under the change-of-control severance policy
  • · Filing was signed October 20, 2026, six days after the October 14, 2026 effective date of the agreement
Apollo Global Management, Inc. 8-K neutral materiality 3/10

20-10-2026

Apollo Global Management announced that Meyer "Micky" Malka, founder and managing partner of Ribbit Capital, will join its Board of Directors effective January 1, 2027, expanding the board to 14 directors while maintaining a two-thirds independent composition. The appointment is a board addition rather than an executive change, and the release is a routine governance announcement with no reported financial results or performance metrics.

  • · Malka currently serves on the board of Robinhood Markets, Inc.
  • · Malka co-founded Heptagon Group, Banco Lemon, and Bling Nation/Lemon Inc.; Patagon.com was acquired by Banco Santander in 2000 and Banco Lemon by Banco do Brasil in 2009
  • · Malka holds an economics degree from the Universidad Católica Andrés Bello in Caracas, Venezuela
  • · Gary Cohn, as Lead Independent Director, praised Malka's entrepreneurial track record and global perspective
Inhibikase Therapeutics, Inc. 8-K positive materiality 4/10

20-10-2026

Inhibikase Therapeutics (Nasdaq: IKT) appointed Scott M. Wasserman, MD, to its Board of Directors effective October 19, 2026, while Dennis Berman resigned from the Board concurrently. Dr. Wasserman is currently Chief Medical Officer of Kailera Therapeutics and brings more than two decades of cardiology and clinical development experience, including senior roles at Amgen in the development of Repatha, Evenity, and Aimovig. The announcement is a board governance change with no disclosed financial figures.

  • · Board appointment effective October 19, 2026, one day before the October 20, 2026 announcement
  • · Dennis Berman's resignation from the Board was announced concurrently with the appointment
  • · Dr. Wasserman previously served as Venture Partner at Frazier Life Sciences and as CEO and co-founder of Latigo Biotherapeutics
  • · Filing references Items 5.02, 7.01 and 9.01, with the press release furnished as Exhibit 99.1
ProCap Financial, Inc. 8-K mixed materiality 6/10

20-10-2026

Silvia, Inc. (formerly ProCap Financial, Inc.; Nasdaq: SVIA) announced an aggressive company-wide cost-cutting initiative expected to generate more than $10 million in annualized savings, achieved through reductions in compensation and operating expenses, lower compute and personnel costs, and renegotiated vendor contracts. The release also cites the addition of new executive team members at a more efficient cost structure, and Anthony Pompliano is identified as Chairman and CEO. The filing does not provide the specific officer change details that would normally accompany Items 5.02 disclosures, and the savings are expected to begin in the current fiscal year with full run-rate benefit thereafter.

  • · Company was formerly ProCap Financial, Inc. and changed its name to Silvia, Inc. with a new Nasdaq ticker SVIA
  • · Savings attributed to reduced compute and personnel expenses, renegotiated key vendor contracts, and addition of executives at a more efficient cost structure
  • · Management has not quantified the impact in detail and will provide additional details at the next regularly scheduled financial update
  • · Filing references Item 5.02 (officer departure/election) but the exhibit contains no departure or appointment particulars
  • · Company describes itself as the first publicly traded agentic finance firm and references a website transition in forward-looking statements
ENTRAVISION COMMUNICATIONS CORP 8-K positive materiality 4/10

20-10-2026

Entravision Communications Corporation (NYSE: EVC) appointed Gary Ferrera and Brian Krzanich as independent directors on October 14, 2026, expanding the Board from seven to nine members. Mr. Ferrera joins the Audit Committee; both receive standard non-employee director compensation, including a prorated initial RSU grant. The filing discloses no material financial results, and no departures are reported.

  • · Gary Ferrera was appointed to the Audit Committee
  • · Both directors were determined to be independent under NYSE listing standards and Exchange Act rules
  • · Neither director has a material interest in any related-party transaction under Item 404(a) of Regulation S-K
  • · Directors serve until the 2027 annual meeting of stockholders
  • · Ferrera previously served as CFO at MoneyGram, Driven Brands, and Skillsoft; Krzanich was formerly CEO of CDK Global and Intel
  • · Compensation references the Non-Employee Director Compensation Policy disclosed in Exhibit 10.14 to a Form 10-Q filed August 4, 2023
HUNTINGTON INGALLS INDUSTRIES, INC. 8-K positive materiality 3/10

20-10-2026

HII announced that former CEO and President Mike Petters has been elected to the company's board of directors, returning to a board role after stepping down as CEO in 2022. CEO Chris Kastner and Chairman Kirkland Donald both praised his shipbuilding expertise as HII ramps up capacity for the U.S. Navy. The filing contains no financial results, so no period-over-period performance comparison applies.

  • · Petters stepped down as first CEO and president in 2022 after steering the 2011 spin-off from Northrop Grumman
  • · Petters began at Newport News Shipbuilding in 1987 in the Los Angeles-class submarine construction division
  • · Petters holds a physics bachelor's degree from the U.S. Naval Academy (1982) and an MBA from the College of William and Mary
  • · Petters previously served as chairman of the Virginia Business Council and the Aerospace Industries Association
SUJA LIFE, INC. 8-K positive materiality 4/10

20-10-2026

Suja Life, Inc. (NASDAQ: SUJA) announced the appointments of Robert B. Engel and Zahir Ibrahim as independent directors effective October 16, 2026, expanding the Board to nine members, seven of whom are independent. Engel will join the Audit Committee, and the appointments add financial, accounting, and capital markets expertise as the company pursues its growth strategy. The filing contains no financial results, quantitative performance metrics, or negative developments.

  • · Engel serves as CEO and Managing Director of BLT Advisory Services, LLC, and is an independent director of Allient, Inc. (Audit Committee) and Chairman of Alaska Power & Telephone
  • · Engel previously chaired the Risk Committee at Heartland Financial USA, Inc.
  • · Ibrahim was most recently CFO of BARK, Inc. and led KIND through its 2020 sale to Mars
  • · Ibrahim was earlier CFO of Annie's, Inc., which was sold to General Mills
  • · Suja's brands reach consumers through thousands of retail doors nationally; the company operates a vertically integrated high-pressure processing and cold-pressed facility
Trade Desk, Inc. 8-K mixed materiality 5/10

20-10-2026

The Trade Desk, Inc. effected an option repricing on October 19, 2026, reducing the exercise price of eligible outstanding stock options under its 2025 Incentive Award Plan to $12.26, the closing price on the Effective Date, after stockholders approved the Repricing at a special meeting that day. Options exceeding that closing price were repriced, while incentive stock options and CEO Jeff Green's market-based performance options were excluded. The repricing is intended to restore incentive and retention value without increasing equity overhang.

  • · Repriced options revert to original exercise prices if the service provider terminates (other than termination by the Company without cause) or exercises before April 19, 2027
  • · Proposal One received 441,097,211 votes for and 232,477,009 against, with 299,747 abstentions; Proposal Two (adjournment) was not needed
  • · Class B shares carry 10 votes each, so Class B holders have outsized influence in stockholder votes
  • · CEO Jeff Green's market-based performance options granted in October 2021 and September 2026 were excluded from the repricing
NEWELL BRANDS INC. 8-K positive materiality 5/10

20-10-2026

Newell Brands (NASDAQ: NWL) announced the appointment of Guillermo Beade as Chief Operating Officer, effective October 26, 2026, reporting to CEO Chris Peterson and joining the Executive Committee. The COO role carries enterprise accountability for global sales, central marketing, and supply chain, with a mandate to improve connectivity across these functions and strengthen structure, systems, and talent. The filing discloses no quantitative financial results, guidance, or deal terms.

  • · Beade previously served as President of SC Johnson Consumer Brands North America and as CEO of SC Johnson Lifestyle Brands
  • · Management cites prior simplification of the portfolio and improvements to supply chain and go-to-market models as the basis for the structural change
  • · The filing is an 8-K with Items 5.02 and 9.01, and the press release is furnished as Exhibit 99.1
StubHub Holdings, Inc. 8-K neutral materiality 4/10

20-10-2026

StubHub Holdings, Inc. (NYSE: STUB) disclosed that its Board of Directors appointed Andrew Raab, Co-Founder of investment firm FPR Partners, to fill an existing vacancy as a director effective October 16, 2026, with a term expiring at the 2027 annual meeting. Raab is not expected to serve on any Board committee. The filing also discloses a prior consulting agreement (dated March 27, 2026) with Raab for a three-year term, with RSUs granted at an aggregate grant date fair value of $200,000, and a prior $2.0 million Series O preferred stock purchase by Raab in August 2025.

  • · Raab's director term expires at the Company's 2027 annual meeting of stockholders
  • · Raab previously served as Principal at Hellman and Friedman, Associate at Bain Capital, and Analyst at Donaldson, Lufkin and Jenrette; holds MBA from Stanford GSB and BA from University of Michigan
  • · Raab's director compensation follows the non-employee director program disclosed in the FY2025 10-K filed March 5, 2026 and the proxy filed April 30, 2026
  • · Company will enter its standard indemnification agreement with Raab
  • · Filing discloses a related-party relationship: Raab's prior preferred stock investment and consulting arrangement, which the Company states requires disclosure under Item 404(a) of Regulation S-K
PDS Biotechnology Corp 8-K neutral materiality 5/10

20-10-2026

PDS Biotechnology appointed three new directors (John Dawson CBE, Deborah Ramsdell, and Bruce Wendel), effective October 18, 2026, following the resignations of four existing directors (Stephen Glover, Kamil Ali-Jackson, Gregory Freitag, and Otis Brawley). The board was reconstituted, including new Audit and Compensation committee compositions, to support advancement of PDS0301 toward a Phase 3 trial in metastatic colorectal cancer and partnership efforts for PDS0101. The filing does not disclose financial results, and the governance change is presented as a strategic enhancement rather than a response to a stated performance issue.

  • · Board appointments and resignations effective October 18, 2026; announcement dated October 20, 2026
  • · Otis Brawley's oncology experience was cited by the CEO as having shaped the clinical development strategy
  • · Bruce Wendel currently serves on the board of ImmunityBio; prior board service includes GT BioPharma (Nov 2020 to May 2025) and Verastem (June 2016 to May 2021)
  • · Deborah Ramsdell became CEO of Pluvia Biotech in August 2026, a concurrent external leadership role
  • · Audit Committee is chaired by James Banaag with John Dawson and Bruce Wendel as members
  • · Nominating and Governance Committee includes Dr. Ilian Iliev, who is not a new appointee

Get daily alerts with 12 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 23 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Corporate Board Director Changes SEC Filings

🇺🇸 More from United States

View all →